Natasha Loder is The Economist‘s Health-care correspondent. She covers the pharmaceutical industry, medical science and technology. Between 2011 and 2014 she worked as a foreign correspondent in Chicago, covering the Midwest, American education and agriculture. She is based in Chicago but will return to London as the health-care correspondent in autumn 2015. She has worked at the paper for 14 years, and spent over a decade as the Science and technology correspondent. Here she covered a wide range of subjects in science, technology, medicine and the environment. Prior to joining The Economist she worked as a news reporter for the journal Nature and worked briefly for The Times Higher Education Supplement and Research Fortnight. She has won a number of awards for her work covering the environment and technology.
Natasha moderated the Forum’s discussion on Rare Cancers: Charting a Faster Route to Treatment.